AU2003252701A1 - Medicinal composition for treating thrombopenia - Google Patents

Medicinal composition for treating thrombopenia

Info

Publication number: AU2003252701A1
Authority: AU; Australia
Prior art keywords: medicinal composition; thrombopenia; treating; treating thrombopenia; medicinal
Prior art date: 2002-07-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003252701A

Inventor

Ken Hirose

Shunsuke Kageyama

Junko Matsushita

Makoto Shiozaki

Hiroshi Yamamoto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ajinomoto Co Inc

Original Assignee

Ajinomoto Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-29

Filing date

2003-07-25

Publication date

2004-02-16

2003-07-25 Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc

2004-02-16 Publication of AU2003252701A1 publication Critical patent/AU2003252701A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003252701A 2002-07-29 2003-07-25 Medicinal composition for treating thrombopenia Abandoned AU2003252701A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002219173		2002-07-29
JP2002-219173		2002-07-29
PCT/JP2003/009503 WO2004011030A1 (en)	2002-07-29	2003-07-25	Medicinal composition for treating thrombopenia

Publications (1)

Publication Number	Publication Date
AU2003252701A1 true AU2003252701A1 (en)	2004-02-16

Family

ID=31184727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003252701A Abandoned AU2003252701A1 (en)	2002-07-29	2003-07-25	Medicinal composition for treating thrombopenia

Country Status (3)

Country	Link
JP (1)	JPWO2004011030A1 (en)
AU (1)	AU2003252701A1 (en)
WO (1)	WO2004011030A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006237147B2 (en) *	2005-04-20	2011-04-07	Syngenta Participations Ag	Cyano anthranilamide insecticides
US9266923B2 (en)	2010-06-24	2016-02-23	Gray D. Shaw	Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR960704931A (en) *	1993-09-28	1996-10-09	이나모리 슌스케	Peptide and antithrombotic agents
EP0795608B1 (en) *	1994-11-30	2003-04-09	Ajinomoto Co., Inc.	Antithrombotic agent and anti-von willebrand factor monoclonal antibodies
US6228360B1 (en) *	1998-08-19	2001-05-08	Ajinomoto Co., Inc.	Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody

2003
- 2003-07-25 JP JP2004524163A patent/JPWO2004011030A1/en active Pending
- 2003-07-25 WO PCT/JP2003/009503 patent/WO2004011030A1/en not_active Ceased
- 2003-07-25 AU AU2003252701A patent/AU2003252701A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004011030A1 (en)	2004-02-05
JPWO2004011030A1 (en)	2005-11-24

Similar Documents

Publication	Publication Date	Title
AU2003291103A1 (en)	2004-06-15	Pharmaceutical composition
AU2003278393A1 (en)	2004-06-07	New use for pharmaceutical composition
AU2003250372A1 (en)	2004-01-06	Pharmaceutical composition
AU2003236353A1 (en)	2003-10-20	Photopolymerizable composition
HUP0401612A3 (en)	2006-04-28	Pharmaceutical composition suitable for treating diabetes
AU2000272858A1 (en)	2001-08-14	Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2003282722A1 (en)	2004-04-23	Therapeutic compositions
HUP0600855A2 (en)	2007-02-28	Androgen pharmaceutical composition for treating depression
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2003291642A1 (en)	2004-06-18	Pyrazoloazepine compounds as pharmaceutical agents
ZA200500431B (en)	2006-08-30	Medicinal composition for treating arteriosclerosis
AU2003280799A1 (en)	2004-06-15	Medicinal composition
AU2003252701A1 (en)	2004-02-16	Medicinal composition for treating thrombopenia
AU2003242235A1 (en)	2003-12-31	Antifungal medicinal composition
AU2003280678A1 (en)	2004-05-25	Medicinal composition
AU2003240174A1 (en)	2003-12-22	Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2002331279A1 (en)	2003-02-17	Pharmaceutical composition for treating hypercholesterolaemia
AU2003284623A1 (en)	2004-06-15	Medicinal composition for treating sudden deafness
AUPS188302A0 (en)	2002-05-30	Pharmaceutical composition
AU2003254079A1 (en)	2004-05-04	Composition for treating hemorrhoids
AU2002335161A1 (en)	2004-04-30	Medicinal composition
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
AUPS317302A0 (en)	2002-07-18	Metastable pharmaceutical compositions
HK1074392A (en)	2005-11-11	Metastable pharmaceutical composition
HK1077495A (en)	2006-02-17	Pharmaceutical composition comprising arsenite for the treatment of malignancy

Legal Events

Date	Code	Title	Description
2005-04-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase